BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-01-24 |
|---|---|---|---|---|
| 2022 | $85.51 | $83.32 | $87.2 | -0.83% |
| 2023 | $79.02 | $74.22 | $82.87 | -8.36% |
| 2024 | $65.75 | $58.26 | $73.07 | -23.75% |
| 2025 | $52.22 | $48.93 | $57.03 | -39.43% |
| 2026 | $47.97 | $47.71 | $48.64 | -44.37% |
| 2027 | $48.46 | $47.72 | $51.36 | -43.8% |
| 2028 | $81.13 | $53.56 | $114.62 | -5.9% |
| 2029 | $160.52 | $121.15 | $209.61 | 86.17% |
| 2030 | $276.88 | $221.06 | $321.54 | 221.13% |
| 2031 | $349.31 | $327.25 | $363.17 | 305.13% |
| 2032 | $363.72 | $363.72 | $363.72 | 321.85% |
The 7 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$100.86 with a high forecast of $115.0 and a low forecast of $88.0.
The average BioMarin Pharmaceutical stock forecast represents a 16.98%
increase from the last price of $86.2200012207031.
From AI system, total return is 3138.37% from 3070 forecasts.
For BioMarin Pharmaceutical stock forecast for 2022, 11 predictions are offered for each month of 2022 with average BioMarin Pharmaceutical stock
forecast of $85.51, a high forecast of $87.2, and a low forecast of $83.32.
The average BioMarin Pharmaceutical stock forecast 2022 represents a -0.83%
decrease from the last price of $86.2200012207031.
For BioMarin Pharmaceutical stock forecast for 2023, 12 predictions are offered for each month of 2023 with average BioMarin Pharmaceutical stock
forecast of $79.02, a high forecast of $82.87, and a low forecast of $74.22.
The average BioMarin Pharmaceutical stock forecast 2023 represents a -8.36%
decrease from the last price of $86.2200012207031.
For BioMarin Pharmaceutical stock forecast for 2025, 12 predictions are offered for each month of 2025 with average BioMarin Pharmaceutical stock
forecast of $52.22, a high forecast of $57.03, and a low forecast of $48.93.
The average BioMarin Pharmaceutical stock forecast 2025 represents a -39.43%
decrease from the last price of $86.2200012207031.
For BioMarin Pharmaceutical stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average BioMarin Pharmaceutical stock
forecast of $48.46, a high forecast of $51.36, and a low forecast of $47.72.
The average BioMarin Pharmaceutical stock forecast 2027 represents a -43.8%
decrease from the last price of $86.2200012207031.
For BioMarin Pharmaceutical stock forecast for 2030, 12 predictions are offered for each month of 2030 with average BioMarin Pharmaceutical stock
forecast of $276.88, a high forecast of $321.54, and a low forecast of $221.06.
The average BioMarin Pharmaceutical stock forecast 2030 represents a 221.13%
increase from the last price of $86.2200012207031.
For BioMarin Pharmaceutical stock forecast for 2032 (10 year), 1 predictions are offered for each month of 2032 with average BioMarin Pharmaceutical stock
forecast of $363.72, a high forecast of $363.72, and a low forecast of $363.72.
The average BioMarin Pharmaceutical stock forecast 2032 represents a 321.85%
increase from the last price of $86.2200012207031.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $100.86, and this show a 4.29% increase in average from the prior price target of the each prediction. Also, this average forecast of $100.86 represents a 10.84% increase from the past average forecast of $91.0, 6 months ago from 3 wall street analysts.
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-01-26 | $84.72 | -1.73% |
| 2022-01-27 | $84.59 | -0.16% |
| 2022-01-28 | $83.52 | -1.27% |
| 2022-01-31 | $83.17 | -0.41% |
| 2022-02-01 | $81.09 | -2.50% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Feb. is $86.99 , for 2023 Jan. is $82.87 , for 2026 Jan. is $48.64 , for 2027 Jan. is $47.72 , for 2031 Jan. is $327.25 , and for 2032 Jan. is $363.72.
BMRN : BioMarin Pharmaceutical stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Feb. | $86.99 | 0.89% |
| 2022 Mar. | $87.20 | 0.24% |
| 2022 Apr. | $86.98 | -0.25% |
| 2022 May. | $86.65 | -0.37% |
| 2022 Jun. | $86.21 | -0.51% |
| 2022 Jul. | $85.69 | -0.61% |
| 2022 Aug. | $85.13 | -0.66% |
| 2022 Sep. | $84.59 | -0.63% |
| 2022 Oct. | $84.10 | -0.58% |
| 2022 Nov. | $83.71 | -0.47% |
| 2022 Dec. | $83.32 | -0.47% |
BMRN : BioMarin Pharmaceutical stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $82.87 | -0.54% |
| 2023 Feb. | $82.30 | -0.68% |
| 2023 Mar. | $81.69 | -0.75% |
| 2023 Apr. | $81.05 | -0.78% |
| 2023 May. | $80.39 | -0.82% |
| 2023 Jun. | $79.69 | -0.87% |
| 2023 Jul. | $78.94 | -0.94% |
| 2023 Aug. | $78.13 | -1.02% |
| 2023 Sep. | $77.26 | -1.12% |
| 2023 Oct. | $76.32 | -1.22% |
| 2023 Nov. | $75.31 | -1.33% |
| 2023 Dec. | $74.22 | -1.44% |
BMRN : BioMarin Pharmaceutical stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $73.07 | -1.55% |
| 2024 Feb. | $71.86 | -1.66% |
| 2024 Mar. | $70.59 | -1.77% |
| 2024 Apr. | $69.26 | -1.88% |
| 2024 May. | $67.90 | -1.97% |
| 2024 Jun. | $66.51 | -2.05% |
| 2024 Jul. | $65.10 | -2.12% |
| 2024 Aug. | $63.68 | -2.17% |
| 2024 Sep. | $62.28 | -2.21% |
| 2024 Oct. | $60.90 | -2.22% |
| 2024 Nov. | $59.56 | -2.20% |
| 2024 Dec. | $58.26 | -2.17% |
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $57.03 | -2.11% |
| 2025 Feb. | $55.88 | -2.03% |
| 2025 Mar. | $54.80 | -1.92% |
| 2025 Apr. | $53.81 | -1.81% |
| 2025 May. | $52.90 | -1.68% |
| 2025 Jun. | $52.09 | -1.55% |
| 2025 Jul. | $51.36 | -1.40% |
| 2025 Aug. | $50.72 | -1.24% |
| 2025 Sep. | $50.16 | -1.09% |
| 2025 Oct. | $49.68 | -0.96% |
| 2025 Nov. | $49.28 | -0.82% |
| 2025 Dec. | $48.93 | -0.70% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $48.64 | -0.59% |
| 2026 Feb. | $48.41 | -0.48% |
| 2026 Mar. | $48.22 | -0.39% |
| 2026 Apr. | $48.07 | -0.31% |
| 2026 May. | $47.95 | -0.24% |
| 2026 Jun. | $47.87 | -0.18% |
| 2026 Jul. | $47.80 | -0.13% |
| 2026 Aug. | $47.76 | -0.09% |
| 2026 Sep. | $47.73 | -0.06% |
| 2026 Oct. | $47.72 | -0.03% |
| 2026 Nov. | $47.71 | -0.01% |
| 2026 Dec. | $47.72 | 0.00% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $47.72 | 0.01% |
| 2027 Feb. | $47.73 | 0.02% |
| 2027 Mar. | $47.75 | 0.03% |
| 2027 Apr. | $47.77 | 0.05% |
| 2027 May. | $47.81 | 0.08% |
| 2027 Jun. | $47.88 | 0.13% |
| 2027 Jul. | $47.98 | 0.21% |
| 2027 Aug. | $48.15 | 0.37% |
| 2027 Sep. | $48.46 | 0.63% |
| 2027 Oct. | $48.99 | 1.10% |
| 2027 Nov. | $49.89 | 1.85% |
| 2027 Dec. | $51.36 | 2.93% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $53.56 | 4.28% |
| 2028 Feb. | $56.61 | 5.70% |
| 2028 Mar. | $60.53 | 6.93% |
| 2028 Apr. | $65.23 | 7.78% |
| 2028 May. | $70.58 | 8.19% |
| 2028 Jun. | $76.38 | 8.22% |
| 2028 Jul. | $82.49 | 8.00% |
| 2028 Aug. | $88.77 | 7.62% |
| 2028 Sep. | $95.16 | 7.19% |
| 2028 Oct. | $101.60 | 6.77% |
| 2028 Nov. | $108.09 | 6.39% |
| 2028 Dec. | $114.62 | 6.04% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $121.15 | 5.69% |
| 2029 Feb. | $127.58 | 5.32% |
| 2029 Mar. | $133.91 | 4.96% |
| 2029 Apr. | $140.18 | 4.68% |
| 2029 May. | $146.57 | 4.56% |
| 2029 Jun. | $153.33 | 4.61% |
| 2029 Jul. | $160.70 | 4.81% |
| 2029 Aug. | $168.89 | 5.09% |
| 2029 Sep. | $177.96 | 5.37% |
| 2029 Oct. | $187.87 | 5.57% |
| 2029 Nov. | $198.48 | 5.65% |
| 2029 Dec. | $209.61 | 5.61% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $221.06 | 5.46% |
| 2030 Feb. | $232.60 | 5.22% |
| 2030 Mar. | $244.06 | 4.92% |
| 2030 Apr. | $255.23 | 4.58% |
| 2030 May. | $265.95 | 4.20% |
| 2030 Jun. | $276.06 | 3.80% |
| 2030 Jul. | $285.46 | 3.41% |
| 2030 Aug. | $294.09 | 3.02% |
| 2030 Sep. | $301.94 | 2.67% |
| 2030 Oct. | $309.04 | 2.35% |
| 2030 Nov. | $315.52 | 2.10% |
| 2030 Dec. | $321.54 | 1.91% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $327.25 | 1.77% |
| 2031 Feb. | $332.65 | 1.65% |
| 2031 Mar. | $337.70 | 1.52% |
| 2031 Apr. | $342.34 | 1.37% |
| 2031 May. | $346.54 | 1.23% |
| 2031 Jun. | $350.29 | 1.08% |
| 2031 Jul. | $353.58 | 0.94% |
| 2031 Aug. | $356.42 | 0.80% |
| 2031 Sep. | $358.81 | 0.67% |
| 2031 Oct. | $360.73 | 0.54% |
| 2031 Nov. | $362.18 | 0.40% |
| 2031 Dec. | $363.17 | 0.27% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $363.72 | 0.15% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2022 Feb. is $86.988787522381 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2023 Jan. is $82.8652638785795 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2026 Jan. is $48.6444239344073 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2027 Jan. is $47.7224892666618 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2031 Jan. is $327.245477532809 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2032 Jan. is $363.72007741078
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go DOWN . Therefore, AI Pickup would say that BioMarin Pharmaceutical (BMRN) stock is overvalued.
Will BioMarin Pharmaceutical stock price go up?
No. The BioMarin Pharmaceutical stock price forecast for 2023 Jan. is $82.8652638785795
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2022-01-24 is $86.2200012207031 and forecast for 2023 Jan. is $82.87, BioMarin Pharmaceutical stock is not a good 1 year investment.